Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hare

Showing results (161-170 of 280) with videos related to

Pageof 28
Sort By:
Journal of Medicinal Chemistry|June 1, 1972
Analgetics based on the pyrrolidine ring. 7I M Lockhart, N E Webb, M Wright, et al.
Archives of Neurology|June 1, 1980
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disordersN V Manyam, L Katz, T A Hare, et al.
Brain Research|March 6, 1992
In vivo modulation of excitatory amino acid receptors: microdialysis studies on N-methyl-D-aspartate-evoked striatal dopamine release and effects of antagonistsD P Carrozza, T N Ferraro, G T Golden, et al.
Pharmacology|November 5, 1997
Effects of L-DOPA/carbidopa administration on the levels of L-DOPA, other amino acids and related compounds in the plasma, brain and heart of the ratC Diederich, L Milakofsky, T A Hare, et al.
The New England Journal of Medicine|May 8, 1975
Letter: Low GABA levels in CSF in Huntington's choreaB S Glaeser, T A Hare, W H Vogel, et al.
Brain Research|January 20, 1980
Changes in the free amino acids of the injured spinal cord of the catL J Martinez, J L Alderman, B S Glaeser, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 18, 1973
DOPA and amino acid levels in plasma and cerebrospinal fluid of patients with Parkinson's disease before and during treatment with L-DOPAT A Hare, B L Beasley, R A Chambers, et al.
Brain Research|January 20, 1980
Stability of GABA levels in CSF under various conditions of storageM H Grossman, T A Hare, N V Manyam, et al.
Biological Psychiatry|July 1, 1986
CSF GABA in euthymic manic-depressive patients and controlsW H Berrettini, J I Nurnberger, T A Hare, et al.
Neurology|September 1, 1979
Low cerebrospinal fluid gamma-aminobutyric acid content in seizure patientsJ H Wood, T A Hare, B S Glaeser, et al.
Pageof 28

Showing results (161-170 of 280) with videos related to

Sort By:
Pageof 28
Journal of Medicinal Chemistry|June 1, 1972
Analgetics based on the pyrrolidine ring. 7I M Lockhart, N E Webb, M Wright, et al.
Archives of Neurology|June 1, 1980
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disordersN V Manyam, L Katz, T A Hare, et al.
Brain Research|March 6, 1992
In vivo modulation of excitatory amino acid receptors: microdialysis studies on N-methyl-D-aspartate-evoked striatal dopamine release and effects of antagonistsD P Carrozza, T N Ferraro, G T Golden, et al.
Pharmacology|November 5, 1997
Effects of L-DOPA/carbidopa administration on the levels of L-DOPA, other amino acids and related compounds in the plasma, brain and heart of the ratC Diederich, L Milakofsky, T A Hare, et al.
The New England Journal of Medicine|May 8, 1975
Letter: Low GABA levels in CSF in Huntington's choreaB S Glaeser, T A Hare, W H Vogel, et al.
Brain Research|January 20, 1980
Changes in the free amino acids of the injured spinal cord of the catL J Martinez, J L Alderman, B S Glaeser, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 18, 1973
DOPA and amino acid levels in plasma and cerebrospinal fluid of patients with Parkinson's disease before and during treatment with L-DOPAT A Hare, B L Beasley, R A Chambers, et al.
Brain Research|January 20, 1980
Stability of GABA levels in CSF under various conditions of storageM H Grossman, T A Hare, N V Manyam, et al.
Biological Psychiatry|July 1, 1986
CSF GABA in euthymic manic-depressive patients and controlsW H Berrettini, J I Nurnberger, T A Hare, et al.
Neurology|September 1, 1979
Low cerebrospinal fluid gamma-aminobutyric acid content in seizure patientsJ H Wood, T A Hare, B S Glaeser, et al.
Pageof 28